Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit

[1]  Alimuddin Zumla,et al.  Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study , 2010, The Lancet.

[2]  A. Hoeft,et al.  Improved detection of blood stream pathogens by real-time PCR in severe sepsis , 2009, Intensive Care Medicine.

[3]  T. Albertson,et al.  Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia* , 2008, Critical care medicine.

[4]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[5]  A. Bakhrouf,et al.  DNA fingerprinting of a multi-resistant coagulase-negative staphylococci isolated from biomaterials in dialysis services. , 2006, Archives of medical research.

[6]  S. Jalal,et al.  Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  M. Millar,et al.  Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  M. Weinstein.  Blood Culture Contamination: Persisting Problems and Partial Progress , 2003, Journal of Clinical Microbiology.

[9]  S. Richter,et al.  Minimizing the Workup of Blood Culture Contaminants: Implementation and Evaluation of a Laboratory-Based Algorithm , 2002, Journal of Clinical Microbiology.

[10]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[11]  K. Lee,et al.  Crescent Sign in Invasive Pulmonary Aspergillosis: Frequency and Related CT and Clinical Factors , 2001, Journal of computer assisted tomography.

[12]  Michael L Wilson,et al.  Update on detection of bacteremia and fungemia , 1997, Clinical microbiology reviews.

[13]  G. Parmigiani,et al.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  V. Stanisich,et al.  New approaches to typing and identification of bacteria using the 16S-23S rDNA spacer region. , 1996, Microbiology.

[15]  I. L. Cohen.  Guidelines for the use of innovative therapies in sepsis. , 1993, Critical care medicine.

[16]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[17]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[18]  F. Gannon,et al.  The 16s/23s ribosomal spacer region as a target for DNA probes to identify eubacteria. , 1991, PCR methods and applications.

[19]  A. Dicker,et al.  [Gene amplification by the polymerase chain reaction]. , 2008, Deutsche medizinische Wochenschrift.

[20]  P. Murray.  Determination of the optimum incubation period of blood culture broths for the detection of clinically significant septicemia , 1985, Journal of clinical microbiology.

[21]  J. Campbell,et al.  Evaluation of the necessity for routine terminal subcultures of previously negative blood cultures , 1980, Journal of clinical microbiology.

[22]  W T Haeck,et al.  American College of Emergency Physicians. , 1970, The Journal of the Florida Medical Association.